cinobactin 500 mg kapseli, kova
eli lilly italia s.p.a. - cinoxacinum - kapseli, kova - 500 mg - sinoksasiini
jardiance
boehringer ingelheim international gmbh - empagliflozin - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - diabeetilla käytettävät lääkkeet - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 ja 5. of the annex. heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease.
gabrion 300 mg kapseli, kova
orion corporation - gabapentin - kapseli, kova - 300 mg - gabapentiini
gabrion 400 mg kapseli, kova
orion corporation - gabapentin - kapseli, kova - 400 mg - gabapentiini
toctino 10 mg kapseli, pehmeä
glaxosmithkline oy - alitretinoin - kapseli, pehmeä - 10 mg - alitretinoiini
toctino 30 mg kapseli, pehmeä
glaxosmithkline oy - alitretinoin - kapseli, pehmeä - 30 mg - alitretinoiini
sunitinib avansor 50 mg kapseli, kova
avansor pharma oy - sunitinib malate - kapseli, kova - 50 mg - sunitinibi
sunitinib avansor 25 mg kapseli, kova
avansor pharma oy - sunitinib malate - kapseli, kova - 25 mg - sunitinibi
sunitinib avansor 12.5 mg kapseli, kova
avansor pharma oy - sunitinib malate - kapseli, kova - 12.5 mg - sunitinibi
brietal injektio/infuusiokuiva-aine, liuosta varten
eli lilly finland oy ab - methohexitalum natricum - injektio/infuusiokuiva-aine, liuosta varten - metoheksitaali